Oestrogen and growth factor cross-talk and endoc... [Br J Cancer. 2000] - PubMed

Save items

loading

Related citations in PubMed

Review Growth factor signalling networks in breast cancer and resistance to endocrine agents: new therapeutic strategies. [J Steroid Biochem Mol Biol. 2005]
Review Growth factor signalling networks in breast cancer and resistance to endocrine agents: new therapeutic strategies.
Nicholson RI, Hutcheson IR, Britton D, Knowlden JM, Jones HE, Harper ME, Hiscox SE, Barrow D, Gee JM. J Steroid Biochem Mol Biol. 2005 Feb; 93(2-5):257-62. Epub 2005 Feb 8.
Review Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: new opportunities for therapy. [Endocr Relat Cancer. 2004]
Review Growth factor-driven mechanisms associated with resistance to estrogen deprivation in breast cancer: new opportunities for therapy.
Nicholson RI, Staka C, Boyns F, Hutcheson IR, Gee JM. Endocr Relat Cancer. 2004 Dec; 11(4):623-41.
Review Growth factor signalling and response to endocrine therapy: the Royal Marsden Experience. [Endocr Relat Cancer. 2005]
Review Growth factor signalling and response to endocrine therapy: the Royal Marsden Experience.
Dowsett M, Johnston S, Martin LA, Salter J, Hills M, Detre S, Gutierrez MC, Mohsin SK, Shou J, Allred DC, et al. Endocr Relat Cancer. 2005 Jul; 12 Suppl 1:S113-7.
Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance. [Clin Cancer Res. 2004]
Cross-talk between estrogen receptor and growth factor pathways as a molecular target for overcoming endocrine resistance.
Schiff R, Massarweh SA, Shou J, Bharwani L, Mohsin SK, Osborne CK. Clin Cancer Res. 2004 Jan 1; 10(1 Pt 2):331S-6S.
Acquired resistance to oestrogen deprivation: role for growth factor signalling kinases/oestrogen receptor cross-talk revealed in new MCF-7X model. [Endocr Relat Cancer. 2005]
Acquired resistance to oestrogen deprivation: role for growth factor signalling kinases/oestrogen receptor cross-talk revealed in new MCF-7X model.
Staka CM, Nicholson RI, Gee JM. Endocr Relat Cancer. 2005 Jul; 12 Suppl 1:S85-97.

See reviews... See all...

Cited by 4 PubMed Central articles

GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells. [BMC Cancer. 2011]
GP88 (PC-Cell Derived Growth Factor, progranulin) stimulates proliferation and confers letrozole resistance to aromatase overexpressing breast cancer cells.
Abrhale T, Brodie A, Sabnis G, Macedo L, Tian C, Yue B, Serrero G. BMC Cancer. 2011 Jun 9; 11:231. Epub 2011 Jun 9.
Designer monotransregulators provide a basis for a transcriptional therapy for de novo endocrine-resistant breast cancer. [Mol Med. 2010]
Designer monotransregulators provide a basis for a transcriptional therapy for de novo endocrine-resistant breast cancer.
Nott SL, Huang Y, Kalkanoglu A, Harper K, Chen M, Paoni SF, Fenton BM, Muyan M. Mol Med. 2010 Jan-Feb; 16(1-2):10-8. Epub 2009 Nov 17.
Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells. [Breast Cancer Res Treat. 2010]
Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells.
De Amicis F, Thirugnansampanthan J, Cui Y, Selever J, Beyer A, Parra I, Weigel NL, Herynk MH, Tsimelzon A, Lewis MT, et al. Breast Cancer Res Treat. 2010 May; 121(1):1-11. Epub 2009 Jun 17.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired ...
Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer.
Br J Cancer. 2000 Feb ;82(3):501-13.

PubMed
The prevalence and severity of enamel fluorosis in North American children.
The prevalence and severity of enamel fluorosis in North American children.
J Public Health Dent. 1999 Fall ;59(4):239-46.

PubMed
Analysis of the genetic diversity of Helicobacter pylori: the tale of two genome...
Analysis of the genetic diversity of Helicobacter pylori: the tale of two genomes.
J Mol Med (Berl). 1999 Dec ;77(12):834-46.

PubMed
Social status and susceptibility to respiratory infections.
Social status and susceptibility to respiratory infections.
Ann N Y Acad Sci. 1999 ;896:246-53.

PubMed
Epidemiology of socioeconomic status and health: are determinants within countri...
Epidemiology of socioeconomic status and health: are determinants within countries the same as between countries?
Ann N Y Acad Sci. 1999 ;896:16-29.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Oestrogen and growth factor cross-talk and endocrine insensitivity and acquired resistance in breast cancer.

Source

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 4 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information